Follow
Jasmeet Sidhu
Jasmeet Sidhu
Tata Translational Cancer Research Center, Tata Medical Center
Verified email at ttcrc.tmckolkata.org
Title
Cited by
Cited by
Year
Unsatisfactory quality of E. coli asparaginase biogenerics in India: Implications for clinical outcomes in acute lymphoblastic leukaemia
J Sidhu, MP Gogoi, P Agarwal, T Mukherjee, D Saha, P Bose, P Roy, ...
Pediatric blood & cancer 68 (11), e29046, 2021
132021
Acute Disseminated Encephalomyelitis After Plasmodium Vivax Infection: Case Report and Review of Literature
J Sidhu, A Maheshwari, R Gupta, V Devgan
Pediatric reports 7 (2), 5859, 2015
132015
Maternal and Neonatal Tetanus: A Journey into Oblivion.
J Sidhu, P Dewan, P Gupta
Indian pediatrics 53 (12), 2016
72016
Therapeutic drug monitoring informs asparaginase dose scheduling in the InPOG-ALL-15-01-ICiCLe-ALL-14 trial
J Sidhu, D Saha, P Roy, M Banerjee, P Paul, S Samaddar, A Basu, ...
Pediatric Hematology Oncology Journal 2 (2), S2-S3, 2017
32017
A simple clinical score to predict outcome in hospitalized extramural neonates
J Sidhu, HS Bains
International Journal of Contemporary Pediatrics 2 (1), 32-36, 2015
32015
Activity and toxicity of intramuscular 1000 iu/m2 polyethylene glycol‐E. coli L‐asparaginase in the UKALL 2003 and UKALL 2011 clinical trials
J Sidhu, AN Masurekar, MP Gogoi, C Fong, T Ioannou, T Lodhi, C Parker, ...
British journal of haematology 198 (1), 142-150, 2022
22022
MSC. sensor: Capturing cancer cell interactions with stroma for functional profiling
Y Huang, A Drakul, J Sidhu, KK Rauwolf, J Kim, B Bornhauser, ...
SLAS Discovery 28 (7), 350-354, 2023
12023
Relapsed Acute Lymphoblastic Leukemia
J Sidhu, MP Gogoi, S Krishnan, V Saha
Indian Journal of Pediatrics, 1-10, 2023
12023
Drug response profiling identifies sensitive synergistic drug combinations for patients with refractory/relapsed acute lymphoblastic leukemia
J Sidhu, S Banerjee, A Bhowal, P Das, MP Gogoi, R Siddhanta, K Das, ...
Pediatric Hematology Oncology Journal 7 (4), S2, 2022
12022
Delayed Intensification Including Venetoclax and Bortezomib Prolongs Survival in Very High Risk Acute Lymphoblastic Leukaemia
J Sidhu, A Chakraborty, P Das, MP Gogoi, T Dey, FD Steffen, S Basu, ...
Blood 142, 4244, 2023
2023
Phenotypic Drug Response Profiling Identifies Asparaginase-Based Synergistic Combinations for Very High Risk Acute Lymphoblastic Leukaemia
J Sidhu, FD Steffen, IA Jimenez, Y Huang, KK Rauwolf, A Chakraborty, ...
Blood 142, 417, 2023
2023
Systematic clinical and pharmacological monitoring of a PEG-asparaginase biogeneric (HAMSYL) in paediatric patients with newly-diagnosed acute lymphoblastic leukaemia
D Sengupta, B Jana, B Dasgupta, S Goswami, S Kundu, S Samaddar, ...
Pediatric Hematology Oncology Journal 8 (4), S48, 2023
2023
Unique mutation and gene expression in High Hyperdiploid Acute Lymphoblastic Leukaemia with whole chromosome uniparental isodisomy
M Parihar, D Ganguli, A Banerjee, R Islam, S Basu, C Bhattacharya, ...
2022
Reply to: Comment on: Unsatisfactory quality of E. coli asparaginase biogenerics in India—Implications for clinical outcomes in acute lymphoblastic leukaemia
J Sidhu, V Saha, S Krishnan
Pediatric Blood & Cancer 69 (2), e29334, 2022
2022
The variable quality of commercial E. coli L-Asparaginases in India and the implications for clinical practice
J Sidhu, MP Gogoi, P Bose, NS Kumar, D Saha, P Paul, S Bhagwat, ...
Pediatric Hematology Oncology Journal 5 (4), S3-S4, 2020
2020
Evolving strategies in the management of relapsed acute lymphoblastic leukaemia–TMCKidsALLR1
P Roy, J Sidhu, R Islam, D Saha, M Das, P Paul, S Krishnan, V Saha
Pediatric Hematology Oncology Journal 2 (2), S16, 2017
2017
Iron Deficiency Anemia in Children: Correspondence
J Sidhu, PC Goyal, R Gupta
The Indian Journal of Pediatrics 83, 191-192, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–17